Vivos RDGL
OTC RDGL
$0.05 +0.00 (+4.44%)
As of: Oct 21, 2026 · 11:51 AM EDT

Vivos (RDGL) Operating Leases (2025)

Updated

Vivos (RDGL) recorded Operating Leases of $88,851 in Q4 2025.

Analysis

Vivos (RDGL) Operating Leases (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.70 Bn 237.73 Bn 4.88 Bn
2 Abbott Laboratories 171.57 Bn 142.00 Bn 7.27 Bn
3 Danaher 162.29 Bn 146.10 Bn 3.61 Bn
4 Intuitive Surgical 150.18 Bn 129.60 Bn 1.96 Bn
5 Medtronic 119.47 Bn 84.72 Bn 6.34 Bn
6 Stryker 113.91 Bn 100.03 Bn 4.50 Bn
7 Boston Scientific 65.30 Bn 60.07 Bn 3.85 Bn
8 Becton Dickinson 53.51 Bn 50.66 Bn 2.32 Bn
9 Edwards Lifesciences 50.73 Bn 34.74 Bn 1.35 Bn
10 Vivos 21.28 Mn 11.59 Mn -3,105.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 88,851.00
API Access

Vivos Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=RDGL&period=max&api_key=YOUR_API_KEY